MLICM
RVMD icon

Metropolitan Life Insurance Company (MetLife)’s Revolution Medicines RVMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,328
Closed -$236K – 1710
2024
Q1 		$236K Sell
7,328
-849
-10% -$25.2K 0.01% 651
2023
Q4 		$235K Buy
8,177
+2,335
+40% +$56.1K 0.01% 671
2023
Q3 		$162K Buy
5,842
+302
+5% +$8.96K 0.01% 775
2023
Q2 		$148K Buy
5,540
+890
+19% +$21.8K 0.01% 817
2023
Q1 		$101K Sell
4,650
-11
-0.2% -$271 0.01% 988
2022
Q4 		$111K Buy
4,661
+180
+4% +$3.83K 0.01% 993
2022
Q3 		$88.4K Buy
4,481
+576
+15% +$12.7K ﹤0.01% 1086
2022
Q2 		$76.1K Hold
3,905
– – ﹤0.01% 1227
2022
Q1 		$99.6K Sell
3,905
-12,643
-76% -$275K ﹤0.01% 1197
2021
Q4 		$417K Hold
16,548
– – 0.01% 1555
2021
Q3 		$455K Hold
16,548
– – 0.01% 1524
2021
Q2 		$525K Buy
16,548
+5,439
+49% +$190K 0.01% 1491
2021
Q1 		$510K Sell
11,109
-327
-3% -$14.7K 0.01% 1397
2020
Q4 		$453K Hold
11,436
– – 0.01% 1422
2020
Q3 		$398K Buy
11,436
+6,477
+131% +$179K 0.01% 1369
2020
Q2 		$157K Hold
4,959
– – ﹤0.01% 1976
2020
Q1 		$109K Buy
+4,959
New +$137K ﹤0.01% 1984

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RVMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Revolution Medicines (RVMD) in Q2 2024, closing a stake of 7,328 shares — an estimated $236K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RVMD in Q1 2020 and held it in 17 quarters. The position peaked at $525K in Q2 2021. 223 funds tracked by Wall St. Rank hold RVMD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Revolution Medicines position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,328 Revolution Medicines shares in Q2 2024, an estimated $236K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Revolution Medicines in Q1 2020 and held it in 17 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Revolution Medicines position peaked at $525K in Q2 2021.
  • 223 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.